{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:55:13Z","timestamp":1792169713798,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI136556"],"award-info":[{"award-number":["R21AI136556"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["AU-0042-20030616"],"award-info":[{"award-number":["AU-0042-20030616"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.virol.2020.07.009","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T08:02:31Z","timestamp":1595404951000},"page":"182-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection"],"prefix":"10.1016","volume":"548","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3595-2071","authenticated-orcid":false,"given":"Matthew L.","family":"Goodwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3046-7053","authenticated-orcid":false,"given":"Helen S.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9248-4281","authenticated-orcid":false,"given":"Hsuan-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6865-5615","authenticated-orcid":false,"given":"Jennifer A.","family":"Jenks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1046-455X","authenticated-orcid":false,"given":"Cody S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9391-3375","authenticated-orcid":false,"given":"Joshua J.","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7871-9969","authenticated-orcid":false,"given":"Jesse F.","family":"Mangold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8878-8407","authenticated-orcid":false,"given":"Sarah","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Pollara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0538-9647","authenticated-orcid":false,"given":"Daniel","family":"Wrapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Ming","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Freed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5666-8622","authenticated-orcid":false,"given":"Dai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9309-2335","authenticated-orcid":false,"given":"Zhiqiang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1438-4554","authenticated-orcid":false,"given":"Sallie R.","family":"Permar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virol.2020.07.009_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/infdis\/171.1.26","article-title":"Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age","volume":"171","author":"Adler","year":"1995","journal-title":"J. Infect. Dis."},{"issue":"1\u20132","key":"10.1016\/j.virol.2020.07.009_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J. Immunol. Methods"},{"issue":"24","key":"10.1016\/j.virol.2020.07.009_bib3","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1073\/pnas.1800224115","article-title":"Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies","volume":"115","author":"Baraniak","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.virol.2020.07.009_bib4","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/infdis\/jiy102","article-title":"Epitope-specific humoral Responses to human cytomegalovirus glycoprotein-B vaccine with MF59: anti-AD2 levels correlate with protection from viremia","volume":"217","author":"Baraniak","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.virol.2020.07.009_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: a randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.virol.2020.07.009_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.virol.2020.07.009_bib7","doi-asserted-by":"crossref","first-page":"e1005355","DOI":"10.1371\/journal.ppat.1005355","article-title":"The march towards a vaccine for congenital CMV: rationale and models","volume":"12","author":"Bialas","year":"2016","journal-title":"PLoS Pathog."},{"issue":"12","key":"10.1016\/j.virol.2020.07.009_bib8","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/infdis\/jiw487","article-title":"Maternal antibody Responses and nonprimary congenital cytomegalovirus Infection of HIV-1-Exposed infants","volume":"214","author":"Bialas","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.virol.2020.07.009_bib9","doi-asserted-by":"crossref","first-page":"e1006601","DOI":"10.1371\/journal.ppat.1006601","article-title":"Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus","volume":"13","author":"Bootz","year":"2017","journal-title":"PLoS Pathog"},{"issue":"18","key":"10.1016\/j.virol.2020.07.009_bib10","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJM200105033441804","article-title":"Lisa; folwer, karen; mach, michael; Britt, william, intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity","volume":"344","author":"Boppana","year":"2001","journal-title":"The New England Jouranal of Medicine"},{"key":"10.1016\/j.virol.2020.07.009_bib11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/infdis\/171.5.1115","article-title":"Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection","volume":"171","author":"Boppana","year":"1995","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 4","key":"10.1016\/j.virol.2020.07.009_bib12","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1093\/cid\/cit629","article-title":"Congenital cytomegalovirus infection: clinical outcome","volume":"57","author":"Boppana","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"1\u20132","key":"10.1016\/j.virol.2020.07.009_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jim.2005.06.018","article-title":"CD16 polymorphisms and NK activation induced by monoclonal antibody-coated target cells","volume":"304","author":"Bowles","year":"2005","journal-title":"J. Immunol. Methods"},{"issue":"10","key":"10.1016\/j.virol.2020.07.009_bib14","doi-asserted-by":"crossref","first-page":"e1005227","DOI":"10.1371\/journal.ppat.1005227","article-title":"Crystal structure of the human cytomegalovirus glycoprotein B","volume":"11","author":"Burke","year":"2015","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.virol.2020.07.009_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/421496","article-title":"Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients","volume":"39","author":"Coaquette","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virol.2020.07.009_bib16","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.4049\/jimmunol.1402281","article-title":"Antibody-mediated response of NKG2Cbright NK cells against human cytomegalovirus","volume":"194","author":"Costa-Garcia","year":"2015","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2020.07.009_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jcv.2010.03.005","article-title":"Human cytomegalovirus (HCMV) genotype populations in immunocompetent individuals during primary HCMV infection","volume":"48","author":"Gorzer","year":"2010","journal-title":"J. Clin. Virol."},{"issue":"9773","key":"10.1016\/j.virol.2020.07.009_bib18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial","volume":"377","author":"Griffiths","year":"2011","journal-title":"Lancet"},{"issue":"5784","key":"10.1016\/j.virol.2020.07.009_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1126548","article-title":"Crystal Structure of glycoprotein B from herpes simplex virus 1","volume":"313","author":"Heldwein","year":"2006","journal-title":"Science"},{"issue":"12\u201313","key":"10.1016\/j.virol.2020.07.009_bib20","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.micinf.2008.08.001","article-title":"Strain-specific seroepidemiology and reinfection of cytomegalovirus","volume":"10","author":"Ishibashi","year":"2008","journal-title":"Microb. Infect."},{"issue":"1\u20132","key":"10.1016\/j.virol.2020.07.009_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.virol.2013.06.002","article-title":"Neutralizing antibodies are unable to inhibit direct viral cell-to-cell spread of human cytomegalovirus","volume":"444","author":"Jacob","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virol.2020.07.009_bib22","article-title":"Antibody binding to native cytomegalovirus glycoprotein B predicts vaccine efficacy","author":"Jenks","year":"2020","journal-title":"medRxiv"},{"issue":"3","key":"10.1016\/j.virol.2020.07.009_bib23","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/AAC.04295-14","article-title":"A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types","volume":"59","author":"Kauvar","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.virol.2020.07.009_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev. Med. Virol."},{"issue":"2","key":"10.1016\/j.virol.2020.07.009_bib25","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/JVI.73.2.878-886.1999","article-title":"Strain-specific Neutralization of human cytomegalovirus Isolates by human sera","volume":"73","author":"Klein","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2020.07.009_bib26","series-title":"Medical Microbiology B. S","article-title":"Immune Defenses","author":"Klimpel","year":"1996"},{"key":"10.1016\/j.virol.2020.07.009_bib27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrneph.2010.141","article-title":"Management of Cytomegalovirus infection in solid organ transplantation","volume":"12","author":"Kotton","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.virol.2020.07.009_bib28","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1182\/blood-2008-05-157354","article-title":"Human NK cells can control CMV infection in the absence of T cells","volume":"112","author":"Kuijpers","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.virol.2020.07.009_bib29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fimmu.2016.00288","article-title":"Antibody-dependent NK cell activation is Associated with late kidney allograft Dysfunction and the complement-independent alloreactive Potential of donor-specific antibodies","volume":"7","author":"Legris","year":"2016","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2020.07.009_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \"silent\" global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"issue":"12","key":"10.1016\/j.virol.2020.07.009_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123982","article-title":"A native human monoclonal antibody targeting HCMV gB (AD-2 site I)","volume":"19","author":"McVoy","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.virol.2020.07.009_bib32","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1099\/0022-1317-73-9-2375","article-title":"Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies","volume":"73","author":"Meyer","year":"1992","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.virol.2020.07.009_bib33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00430-012-0263-0","article-title":"Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8+ T cells during MCMV infection","volume":"201","author":"Mitrovic","year":"2012","journal-title":"Med. Microbiol. Immunol."},{"issue":"24","key":"10.1016\/j.virol.2020.07.009_bib34","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions","volume":"115","author":"Nelson","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.virol.2020.07.009_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01695-18","article-title":"Intrahost Dynamics of human cytomegalovirus variants Acquired by seronegative glycoprotein B vaccinees","volume":"93","author":"Nelson","year":"2019","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virol.2020.07.009_bib36","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.virol.2020.07.009_bib37","doi-asserted-by":"crossref","first-page":"e1002172","DOI":"10.1371\/journal.ppat.1002172","article-title":"B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies","volume":"7","author":"Potzsch","year":"2011","journal-title":"PLoS Pathog."},{"issue":"12","key":"10.1016\/j.virol.2020.07.009_bib38","first-page":"14","article-title":"Different functional states of fusion protein gB revealed on human cytomegalovirus by cryo electron tomography with Volta phase plate","author":"Rey","year":"2018","journal-title":"PLoS Pathog."},{"issue":"12","key":"10.1016\/j.virol.2020.07.009_bib39","doi-asserted-by":"crossref","first-page":"e1007452","DOI":"10.1371\/journal.ppat.1007452","article-title":"Different functional states of fusion protein gB revealed on human cytomegalovirus by cryo electron tomography with Volta phase plate","volume":"14","author":"Si","year":"2018","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.virol.2020.07.009_bib40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00007890-198508000-00010","article-title":"The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation","volume":"40","author":"Smiley","year":"1985","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.virol.2020.07.009_bib41","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1099\/0022-1317-80-8-2183","article-title":"Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization","volume":"80","author":"Speckner","year":"1999","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.virol.2020.07.009_bib42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.coi.2007.07.012","article-title":"Acceleration of allograft failure by cytomegalovirus","volume":"19","author":"Streblow","year":"2007","journal-title":"Curr. Opin. Immunol."},{"issue":"7","key":"10.1016\/j.virol.2020.07.009_bib43","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1128\/JCM.41.7.2872-2877.2003","article-title":"Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR","volume":"41","author":"Tarrago","year":"2003","journal-title":"J. Clin. Microbiol."},{"issue":"13","key":"10.1016\/j.virol.2020.07.009_bib44","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1128\/JVI.01096-13","article-title":"Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity","volume":"87","author":"Wu","year":"2013","journal-title":"J. Virol."},{"issue":"43","key":"10.1016\/j.virol.2020.07.009_bib45","doi-asserted-by":"crossref","first-page":"73654","DOI":"10.18632\/oncotarget.18359","article-title":"Active evolution of memory B-cells specific to viral gH\/gL\/pUL 128\/130\/131 pentameric complex in healthy subjects with silent human cytomegalovirus infection","volume":"8","author":"Xia","year":"2017","journal-title":"Oncotarget"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682220301367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682220301367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:40:28Z","timestamp":1792168828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682220301367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":45,"alternative-id":["S0042682220301367"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2020.07.009","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.01.14.907204","asserted-by":"object"}]},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2020.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}